New study finds nanoparticles show promise in therapy for triple-negative breast cancer
WASHINGTON (Oct. 1, 2018) -- Approximately 10-20 percent of diagnosed breast cancers are found to be triple-negative, meaning the breast cancer cells test negative for...






